CCK-8 assays, scratch wound healing experiments, transwell assays, and colony formation assays revealed that PDCL3 significantly promotes tumor cell proliferation, migration, invasion, and colony-forming ability, aligning with our bioinformatics predictions and confirming PDCL3 as an oncogenic gene in LIHC. The gene discussed is PDCL3; the disease is neoplasm.